Dyne Therapeutics Inc (NAS:DYN)
$ 26.49 +0.25 (+0.95%) Market Cap: 4.95 Bil Enterprise Value: 4.27 Bil PE Ratio: 0 PB Ratio: 6.25 GF Score: 34/100

Dyne Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 4, 2026 / 04:50 PM GMT
Release Date Price: $15.23 (+4.32%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DYN.OQ - Dyne Therapeutics Inc
Dyne Therapeutics Inc at TD Cowen Healthcare Conference
Mar 04, 2026 / 04:50PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right, I guess we can get started. My name is Peyton Bontek. I'm a Vice President here on the Biotech Equity Research Team at TD Cowan. We're pleased to have here Eric Lucero, the CFO from DN, and we're looking forward to hearing all the exciting progress you guys have made.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Right, thank you very much. We'll be making some forward-looking statements, so with that, here is the disclaimer.

My name's Eric Lucera. I'm the CFO of Dyne Therapeutics, and I'm very excited to be here. I've been a client of Cowan's
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot